This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Toulouse, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2019.
Company Filing History:
1 out of 29 
1 out of 5,383 
1 out of 1,853 
Years Active: 2019
Title: Victor Laurent: Innovator in Prostate Cancer Treatment
Introduction
Victor Laurent is a notable inventor based in Saint Sulpice, France. He has made significant contributions to the field of cancer research, particularly in the treatment and diagnosis of prostate cancer. His innovative work has led to the development of a unique patent that addresses critical aspects of cancer progression.
Latest Patents
Victor Laurent holds a patent for the "Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer." This invention focuses on an inhibitor of the expression of chemokine CCL7 or the receptor CCR3, or an inhibitor of the CCL7/CCR3 interaction. The application of this invention is aimed at preventing or treating the extension of prostate cancer outside the prostatic capsule in affected individuals. Additionally, the patent outlines a method for determining the aggressiveness of prostate cancer tumors by assessing the concentration or level of expression of the receptor CCR3 in tumor cell samples.
Career Highlights
Throughout his career, Victor Laurent has worked with esteemed institutions such as the Centre Hospitalier Universitaire de Toulouse and the Centre National de la Recherche Scientifique. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Victor has collaborated with notable colleagues, including Adrien Guerard and Bernard Malavaud. Their joint efforts have further advanced the research and development of effective cancer treatments.
Conclusion
Victor Laurent's contributions to prostate cancer research through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in the medical field.